{"id":"NCT00853749","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","briefTitle":"Immune Response In Children Revaccinated With Pneumococcal Conjugate Vaccine","officialTitle":"REVACCINATION WITH PREVENAR 13 - CHARACTERIZATION OF THE LATE IMMUNE RESPONSE AFTER POLYSACCHARIDE (REPLAY).","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-05-05","primaryCompletion":"2009-12-16","completion":"2009-12-16","firstPosted":"2009-03-02","resultsPosted":"2011-01-05","lastUpdate":"2021-11-11"},"enrollment":89,"design":{"allocation":"NON_RANDOMIZED","model":null,"masking":"NONE","primaryPurpose":"OTHER"},"conditions":["Invasive Pneumococcal Disease"],"interventions":[{"type":"BIOLOGICAL","name":"13-valent pneumococcal conjugate vaccine (13vPnC)","otherNames":[]},{"type":"PROCEDURE","name":"Blood draw","otherNames":[]}],"arms":[{"label":"Single","type":"OTHER"}],"summary":"The primary purpose of this study is to evaluate the immune response to 13-valent pneumococcal conjugate vaccine (13vPnCV) in children who as infants received either a complete series of PnCV versus a combination of PnCV and pneumococcal polysaccharide vaccine (PSV). This study is also intended to evaluate the safety of the 13vPnC.","primaryOutcome":{"measure":"Percentage of Participants Achieving a Predefined Serotype-specific Immunoglobulin G (IgG) Antibody Concentration Greater Than or Equal to ( â‰¥) 0.35 Micrograms Per Milliliter (mcg/mL) Measured 1 Month After Vaccination","timeFrame":"Day 28","effectByArm":[{"arm":"PCV/23vPS/13vPnC","deltaMin":100,"sd":null},{"arm":"PCV/PCV/13vPnC","deltaMin":97.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"5 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":2,"countries":["Iceland"]},"refs":{"pmids":["24300594"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=6096A1-3013&StudyName=Immune%20Response%20In%20Children%20Revaccinated%20With%20Pneumococcal%20Conjugate%20Vaccine"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":50},"commonTop":["Tenderness (Any)","Redness (Any)","Swelling (Any)","Redness (Moderate)","Swelling (Moderate)"]}}